Recombinant Human Granulocyte Colony-stimulating Factor Injection

KYOWA KIRIN CO., LTD.🇨🇳 National Medical Products Administration

Approval Id: 509b2af14cf1cfae
Approval Number: 国药准字SJ20171037
Generic Name: 重组人粒细胞刺激因子注射液
Generic Name En: Recombinant Human Granulocyte Colony-stimulating Factor Injection
Trade Name: 惠尔血
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 300μg/0.7ml/支
Reg Date: 2023-02-06
Expired Date: 2027-08-09
Company Name: KYOWA KIRIN CO., LTD.
Company Detail Path: /organization/kyowa-kirin-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 6, 2023

Approval ID

509b2af14cf1cfae

Type

生物制品